Doctor Pop-Up alerts aim to boost kidney disease treatment

NCT ID NCT07430930

First seen Mar 14, 2026 · Last updated Jun 22, 2026 · Updated 15 times

Summary

This study tests whether a computer alert that pops up when doctors open a patient's chart can increase prescriptions of recommended medications for chronic kidney disease. About 1000 patients will take part. The alert shows the patient's lab results and suggests medications they should be on but aren't. Researchers will check if more patients get the right drugs within 90 days.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Yale New Haven Health

    New Haven, Connecticut, 06520, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Best practice alert and order set (a computer pop-up for doctors)

What this could lead to

If it works, this could show that simple computer alerts help doctors prescribe better treatments for kidney disease, improving patient care.

What could go wrong

This is a small, early-stage trial at one center. It tests a behavior change, not a new drug, so results may not apply elsewhere or change long-term outcomes.

Conditions

The condition(s) this trial relates to.

chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.